Antifibrinolytic agents in traumatic haemorrhage.

Coats, Timothy J.; Hunt, Beverly; Roberts, Ian; Shakur, Haleema

journal.pmed.0020064.pdf (103.37 kB)

Antifibrinolytic agents in traumatic haemorrhage.

journal contribution

posted on 2012-10-24, 09:02 authored by Timothy J. Coats, Beverly Hunt, Ian Roberts, Haleema Shakur

This article is an invitation to doctors around the world to participate in the CRASH-2 trial (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage), a large, multi-centre, randomised controlled trial of a simple and widely practicable treatment for traumatic hemorrhage. The rationale for the trial and contact details for those who would like to take part are given below. [Introduction]

History

Citation

PLOS Medicine, 2005, 2 (3), e64

Version

VoR (Version of Record)

Published in

PLOS Medicine

Publisher

Public Library of Science

eissn

1549-1676

Copyright date

2005

Available date

2012-10-24

Publisher DOI

https://doi.org/10.1371/journal.pmed.0020064

Publisher version

http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020064

Language

eng

Administrator link

https://leicester.figshare.com/account/articles/10110662

Usage metrics

Keywords

Antifibrinolytic Agents Hemorrhage Humans Multicenter Studies as Topic Randomized Controlled Trials as Topic Wounds and Injuries

Antifibrinolytic agents in traumatic haemorrhage.

History

Citation

Version

Published in

Publisher

eissn

Copyright date

Available date

Publisher DOI

Publisher version

Language

Administrator link

Usage metrics

Categories

Keywords

Licence

Exports